|
SAMD12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.834600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.237800E-01 |
| Normal-vs-Stage2 |
4.000000E-01 |
| Normal-vs-Stage3 |
5.879600E-01 |
| Normal-vs-Stage4 |
4.861400E-01 |
| Stage1-vs-Stage2 |
9.141400E-01 |
| Stage1-vs-Stage3 |
4.397500E-02 |
| Stage1-vs-Stage4 |
8.681800E-01 |
| Stage2-vs-Stage3 |
1.458580E-01 |
| Stage2-vs-Stage4 |
8.268800E-01 |
| Stage3-vs-Stage4 |
1.904990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.341800E-01 |
| Normal-vs-AfricanAmerican |
5.240400E-02 |
| Normal-vs-Asian |
8.453200E-01 |
| Caucasian-vs-AfricanAmerican |
4.844000E-02 |
| Caucasian-vs-Asian |
8.761600E-01 |
| AfricanAmerican-vs-Asian |
6.440100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.730400E-01 |
| Normal-vs-Female |
5.141600E-01 |
| Male-vs-Female |
8.749800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.160400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.705200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.087600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.925800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.505970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.586180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.220200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.290800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.236400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.356600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.642100E-03 |
| Classical-VS-Follicular |
5.316000E-01 |
| Classical-VS-Other |
4.793200E-01 |
| Classical-VS-Normal |
1.988620E-01 |
| Tall-VS-Follicular |
5.304300E-02 |
| Tall-VS-Other |
5.100200E-01 |
| Tall-VS-Normal |
1.930410E-01 |
| Follicular-VS-Other |
4.991400E-01 |
| Follicular-VS-Normal |
5.871600E-01 |
| Other-VS-Normal |
8.639600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.078000E-01 |
| Normal-vs-N1 |
9.602200E-01 |
| N0-vs-N1 |
7.470800E-01 |
|
|
